IL-33 can attenuate hepatic steatosis and act as an alarmin by quickly triggering the immune system to respond to virus invasion and toxicant-induced damage, thus leading to a protective effect on viral hepatitis and Con A-induced liver injury. The gene discussed is IL33; the disease is fatty liver disease.